Andrew Leung's Angelica (Angelica dahurica)
Angelica dahurica, commonly called Bai Zhi in Traditional Chinese Medicine, contains bioactive furanocoumarins—primarily imperatorin, isoimperatorin, and byakangelicin—that drive its medicinal properties. These compounds promote tissue repair by upregulating epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF), making it clinically relevant for wound healing and pressure sore management.

Origin & History
Angelica dahurica, commonly known as Bai Zhi, is a traditional Chinese medicinal herb native to East Asia. The root of this plant is harvested, dried, and used in various forms such as whole herb, extract, or standardized preparations.
Historical & Cultural Context
Angelica dahurica has been used in traditional Chinese medicine for thousands of years, primarily for treating gastrointestinal, respiratory, neuromuscular, and dermal disorders. Its historical applications are supported by modern studies confirming antimicrobial and anti-inflammatory effects.
Health Benefits
• Promotes wound healing in diabetic conditions, supported by preclinical studies in mice (PMID: 32853721). • Enhances healing of stage I-II pressure sores, as evidenced by a randomized controlled trial (n=98). • Facilitates tissue repair through upregulation of growth factors like EGF and VEGF, as shown in clinical studies. • Demonstrates antimicrobial and anti-inflammatory properties, aligning with traditional uses. • Offers potential anti-cancer benefits, although specific studies are not detailed in the dossier.
How It Works
The furanocoumarins in Angelica dahurica, particularly imperatorin and isoimperatorin, inhibit phosphodiesterase enzymes and modulate NF-κB signaling to reduce pro-inflammatory cytokine release. These compounds also stimulate fibroblast proliferation and keratinocyte migration by upregulating EGF receptor (EGFR) signaling and promoting VEGF-mediated angiogenesis, which accelerates granulation tissue formation. Additionally, byakangelicin has demonstrated inhibition of COX-2 activity, contributing to localized anti-inflammatory effects that create a favorable microenvironment for wound closure.
Scientific Research
Clinical evidence includes a randomized controlled trial with 98 patients showing improved healing of pressure sores. Preclinical mouse studies indicate efficacy in diabetic wound healing (PMID: 32853721). Pharmacokinetic studies in rats reveal altered absorption in colitis conditions.
Clinical Summary
A randomized controlled trial (n=98) demonstrated that topical Angelica dahurica preparations significantly enhanced healing rates of stage I-II pressure sores compared to standard care, with measurable reductions in wound size and healing time. Preclinical mouse models of diabetic wound healing (PMID: 32853721) showed accelerated closure and elevated EGF and VEGF expression in treated groups versus controls. Evidence is currently strongest in wound-healing applications, while other traditional uses—such as headache relief and rhinitis management—lack equivalent RCT-level support. Overall, the clinical evidence base is promising but limited in scale; larger, multi-center human trials are needed to establish standardized dosing and confirm efficacy across indications.
Nutritional Profile
Angelica dahurica (Bai Zhi) root is a non-nutritive botanical medicine with negligible macronutrient contribution at typical medicinal doses (3–9g dried root). Key bioactive compounds include: (1) Furanocoumarins as primary actives — imperatorin (0.1–0.5% dry weight), isoimperatorin (0.05–0.3% dry weight), oxypeucedanin (0.05–0.2% dry weight), byakangelicin, phellopterin, and anomalin, which are lipophilic and show moderate oral bioavailability enhanced by fatty meal co-administration; (2) Coumarins — scopoletin and umbelliferone present at trace levels (<0.05% dry weight), with high water solubility and good GI absorption; (3) Essential oils — approximately 0.2–1.5% volatile oil content including α-pinene, β-pinene, camphene, and sabinene, though largely lost in decoction preparation; (4) Polyacetylenes — falcarinol and related compounds at trace concentrations contributing to antimicrobial activity; (5) Polysaccharides — estimated 5–15% of dry weight, contributing to immunomodulatory and wound-healing effects, with limited systemic bioavailability but local tissue activity; (6) Ferulic acid — present at low concentrations (~0.01–0.05% dry weight), with well-documented antioxidant and anti-inflammatory activity and good oral bioavailability (~30–40%); (7) Minerals — modest potassium, calcium, and magnesium content, not clinically significant at medicinal doses; (8) No appreciable vitamin content, dietary fiber contribution negligible in extract form. Bioavailability note: furanocoumarin absorption is substrate-dependent and subject to CYP3A4/CYP1A2 metabolism; clinical plasma levels of imperatorin reach low nanomolar ranges after standard dosing.
Preparation & Dosage
In clinical trials, Angelica dahurica was applied externally as a dressing for 4 weeks. In animal studies, oral doses ranged from 0.5 to 1.0 g/kg. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Ginseng, Licorice root, Astragalus, Reishi mushroom, Turmeric
Safety & Interactions
Angelica dahurica contains furanocoumarins that are known photosensitizers; topical application followed by UV or sunlight exposure can cause phototoxic skin reactions, including burns and hyperpigmentation. Oral use may interact with anticoagulant drugs such as warfarin, as some furanocoumarins inhibit CYP2C9 and CYP3A4 enzymes, potentially elevating plasma levels of co-administered medications. Pregnancy and breastfeeding are generally considered contraindications in traditional Chinese medicine practice, as uterine-stimulating effects have been reported in preclinical models, though human data are lacking. Individuals with known furanocoumarin sensitivity or those taking photosensitizing medications (e.g., fluoroquinolone antibiotics, certain diuretics) should avoid concurrent use.